Contemporary Pediatrics

Contemporary Pediatrics Expert Clinical Advice for Today's Pediatrician

A pediatric First Seizure Clinic model reduced time to specialist evaluation to days, enabling earlier diagnosis, testin...
12/22/2025

A pediatric First Seizure Clinic model reduced time to specialist evaluation to days, enabling earlier diagnosis, testing, and treatment decisions.

Study author Gogi K., MD, FAES, of Dayton Children's Hospital, explains the reason behind the clinic and study results.

Read more: https://hubs.li/Q03YS7hk0

🥜 Early peanut introduction can prevent peanut allergy—but only if families get the right guidance.A new study found tha...
12/21/2025

🥜 Early peanut introduction can prevent peanut allergy—but only if families get the right guidance.

A new study found that many parents remain confused about the purpose, timing, and safety of introducing peanut-containing foods, even years after national guidelines were released.

Parents reported that pediatricians are their most trusted source of information—highlighting the importance of clear, consistent counseling during well-child visits.

🔗 Read more:
https://hubs.li/Q03YKxXH0

12/21/2025

In our Sunday Spotlight video of the week, Mimi C. Lee MDPhD, of GeneDx explains the mechanism of whole genome and exome testing, highlighting the company's ExomeDx test and GenomeDx tests.

WATCH:

In this Q&A with Carlos A. Bacino, MD, of Baylor College of Medicine, we highlight the November data published in JAMA P...
12/20/2025

In this Q&A with Carlos A. Bacino, MD, of Baylor College of Medicine, we highlight the November data published in JAMA Pediatrics regarding navepegritide (TransCon CNP) in children with . With an updated PDUFA date of February 28, 2026, Bacino breaks down what a potential approval could mean for the landscape and what providers should know.

Read more: https://hubs.li/Q03YMjlb0

In our Article of the Week, we explore recent allergy and Peanut Patch data (DBV Technologies) with commentary from ...
12/20/2025

In our Article of the Week, we explore recent allergy and Peanut Patch data (DBV Technologies) with commentary from principal investigator David Fleischer, MD, of Children's Hospital Colorado.

Phase 3 data show the VIASKIN Peanut patch improved desensitization versus placebo in children aged 4–7 years, supporting a planned FDA BLA in 2026.

Full details: https://hubs.ly/Q03YMTqZ0

As 2026 approaches, we take a look back at some of the major changes to the pediatric schedule, changes to the CDC's A...
12/19/2025

As 2026 approaches, we take a look back at some of the major changes to the pediatric schedule, changes to the CDC's ACIP members, and what providers need to know to reassure families in the new year and beyond.

Read our This Year in Medicine recap: https://hubs.li/Q03YKQ1b0

Join experts Naiem Issa, MD, PhD; Shanna Miranti, MPAS, PA-C; and Jennifer Ornelas, MD, MAS to learn strategies for impr...
12/19/2025

Join experts Naiem Issa, MD, PhD; Shanna Miranti, MPAS, PA-C; and Jennifer Ornelas, MD, MAS to learn strategies for improving pediatric atopic dermatitis care across all severities. They discuss current standards, reducing disease burden, & emerging topical therapies showing how individualized, evidence based, family centered care can boost symptom control, family quality of life, and long term skin health.

Watch now: https://hubs.li/Q03YKWDW0

New from the today:The agency has approved Grifols' fibrinogen, human-chmt (Fesilty) for the treatment of acute bleed...
12/19/2025

New from the today:

The agency has approved Grifols' fibrinogen, human-chmt (Fesilty) for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency (CFD), including hypo- or afibrinogenemia.

MORE https://hubs.li/Q03YJSsL0

12/18/2025

A new Special Report, "Advances in Type 1 Diabetes Management," is now free to watch on Contemporary Pediatrics!

In this 6-part series, Herbert Bravo, MD, of The Pediatric Lounge podcast, and Marian Rewers, MD, PhD, professor of Pediatrics, University of Colorado School of Medicine, Barbara Davis Center, discuss earlier detection, the latest developments, and screening efforts in a peer-to-peer format.

Meet our guests in the video below, and click here for access to the full series: https://www.contemporarypediatrics.com/video-series/special-report-advances-in-type-1-diabetes-management

12/18/2025

New today:

The FDA has provided clearance for Abbott's Amplatzer Piccolo Delivery System, a device designed to be used with the company’s Amplatzer Piccolo Occluder to treat premature infants with patent ductus arteriosus (PDA) (including babies weighing as little as 2 pounds).

MORE: https://hubs.li/Q03YCqC50

DBV Technologies announced positive topline results from VITESSE, a pivotal-phase 3 clinical trial evaluating the VIASKI...
12/17/2025

DBV Technologies announced positive topline results from VITESSE, a pivotal-phase 3 clinical trial evaluating the VIASKIN Peanut patch for the treatment of peanut allergy in children aged 4 to 7 years.

📖Read more on the approval here: https://hubs.li/Q03Yx9Nk0

ICYMI: Yesterday, the approved GSK's depemokimab-ulaa (Exdensur) as an add-on treatment for severe (characterized b...
12/17/2025

ICYMI:

Yesterday, the approved GSK's depemokimab-ulaa (Exdensur) as an add-on treatment for severe (characterized by an eosinophilic phenotype in adult and pediatric patients aged 12 years and older.

More on the twice-yearly dose here: https://hubs.li/Q03YtvM50

Address

25115 Country Club Boulevard
North Olmsted, OH
44070

Website

Alerts

Be the first to know and let us send you an email when Contemporary Pediatrics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Contemporary Pediatrics:

Shortcuts

Share

Category